Related Experiment Video
Updated: Dec 27, 2025

08:13
In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
20.0K
Development and feasibility of quantitative dynamic cardiac imaging for mice using μSPECT
M A Guerraty1, L C Johnson2, E Blankemeyer2
1Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania, 11-145 South Perelman Tower, 3400 Civic Center Blvd, Philadelphia, PA, 19104, USA. marie.guerraty@pennmedicine.upenn.edu.
Summary
We developed quantitative imaging to assess mouse coronary microvascular function. This non-invasive approach measures blood flow and volume, aiding CMVD research.
Area of Science:
- Cardiovascular Imaging
- Molecular Imaging
- Mouse Models
Background:
- Coronary microvascular disease (CMVD) lacks mechanistic understanding.
- Mouse models are crucial for studying CMVD molecular processes.
- Quantitative imaging is needed to assess coronary microvascular function in mice.
Purpose of the Study:
- To develop quantitative mouse imaging techniques for assessing coronary microvascular function.
- To enable mechanistic studies of coronary microvascular disease (CMVD) using mouse models.
Main Methods:
- Utilized 99mTc-sestamibi with MILabs U-SPECT+ system for myocardial blood flow measurement in mice.
- Determined influx rate constant (K1) and intramyocardial blood volume (IMBV) using SPECT imaging.
- Employed 99mTc and stannous pyrophosphate for red blood cell imaging to assess IMBV.
Main Results:
- Established a quantitative framework for measuring K1 (0.57 ± 0.08 min⁻¹) and IMBV changes.
- Demonstrated a 22.9 ± 3.3% increase in IMBV in wild-type mice under hyperemic conditions.
- Derived Renkin-Crone parameters (α=0.99, β=0.39) for 99mTc-sestamibi extraction fraction.
Conclusions:
- Successfully developed a non-invasive µSPECT-based quantitative imaging framework for mouse microvascular function.
- This method allows for the measurement of K1 and changes in IMBV, advancing CMVD research in mouse models.

